Real-time enrollment status for this acanthamoeba keratitis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:33 PM UTC
| NCT Number | NCT06213649 |
| Recruiting Status | Recruiting |
| Condition | Acanthamoeba Keratitis |
| Phase | PHASE3 |
| Target Enrollment | 232 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Jeremy Keenan, MD, MPH |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of July 17, 2026: Clinical trial NCT06213649 is currently recruiting participants. This phase3 study for acanthamoeba keratitis is actively seeking new participants at 13 locations across the United States. The study is sponsored by Jeremy Keenan, MD, MPH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06213649 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06213649 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.